Unknown

Dataset Information

0

Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar.

ABSTRACT:

SUBMITTER: Abu-Raddad LJ 

PROVIDER: S-EPMC8796790 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2 and Ad26.COV2.S COVID-19 vaccines.
| S-EPMC8689763 | biostudies-literature
Unknown Adverse reactions to the BNT162b2 and mRNA-1273 mRNA COVID-19 vaccines in Japan.
| S-EPMC8747950 | biostudies-literature
Unknown Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
| S-EPMC8262622 | biostudies-literature
Unknown Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data.
| S-EPMC8275842 | biostudies-literature
Unknown Differences in IgG Antibody Responses following BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines.
| S-EPMC8579939 | biostudies-literature
Unknown Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection.
| S-EPMC8664708 | biostudies-literature
Unknown Humoral response to mRNA anti-COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia.
| S-EPMC8632355 | biostudies-literature
Unknown Association of BNT162b2 mRNA and mRNA-1273 Vaccines With COVID-19 Infection and Hospitalization Among Patients With Cirrhosis.
| S-EPMC8278308 | biostudies-literature
Unknown Tolerability of Coronavirus Disease 2019 Vaccines, BNT162b2 and mRNA-1273, in Patients With Thymic Epithelial Tumors.
| S-EPMC8423742 | biostudies-literature
Unknown Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study.
| S-EPMC9277486 | biostudies-literature